《Design of biphenyl-substituted diarylpyrimidines with a cyanomethyl linker as HIV-1 NNRTIs via a molecular hybridization strategy》 was published in Molecules in 2020. These research results belong to Lei, Yuan; Han, Sheng; Yang, Yang; Pannecouque, Christophe; De Clercq, Erik; Zhuang, Chunlin; Chen, Fen-Er. SDS of cas: 768-35-4 The article mentions the following:
A series of biphenyl-substituted diarylpyrimidines I (R1 = H, 2-F, 3-F; R2 = H, 2′-Me, 3′-MeO, 4′-F, etc.) with a cyanomethyl linker were designed using a mol. hybridization strategy. The cell-based anti-HIV assay showed that most of the compounds exhibit moderate to good activities against wild-type HIV-1 and clin. relevant mutant strains with a more favorable toxicity, and the enzymic assay showed they have nanomolar activity against reverse transcriptase (RT). Compound I (R1 = 3-F; R2 = 4′-CN) exhibited the best activity against wild-type HIV-1 with an EC50 (50% HIV-1 replication inhibitory concentration) value of 0.027μM, an acceptable CC50 (50% cytotoxic concentration) value of 36.4μM, and selectivity index of 1361, with moderate activities against the single mutants (EC50: E138K, 0.17μM; Y181C, 0.87μM; K103N, 0.9μM; L100I, 1.21μM, resp.), and an IC50 value of 0.059μM against the RT enzyme, which was six-fold higher than nevirapine. The preliminary structure-activity relationship of these new compounds has been established. The mol. modeling predicted the binding modes of the new compounds with RT, providing mol. insight for further drug design. In the part of experimental materials, we found many familiar compounds, such as (3-Fluorophenyl)boronic acid(cas: 768-35-4SDS of cas: 768-35-4)
(3-Fluorophenyl)boronic acid(cas: 768-35-4) can be used to make novel liquid crystalline fluorobiphenylcyclohexenes and difluoroterphenyls by palladium-catalyzed cross-couplings also used in the synthesis of o-phenylphenols as potent leukotriene B4 receptor agonists.SDS of cas: 768-35-4
Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics